Arizona 2023 Regular Session

Arizona House Bill HB2194

Introduced
1/18/23  
Report Pass
1/30/23  
Report Pass
2/21/23  
Engrossed
2/27/23  
Report Pass
3/21/23  
Report Pass
3/27/23  
Enrolled
4/11/23  
Passed
4/17/23  
Chaptered
4/17/23  

Caption

Drug overdose fatality review teams

Impact

The bill mandates the creation of a data collection system to track drug overdose fatalities, encouraging local jurisdictions to establish their own review teams. The review teams are charged with conducting annual analyses of overdose incidents and analyzing the effectiveness of existing statutes and regulations. By structuring the response to drug fatalities through data-driven investigations, the bill aims to inform policies that could help reduce the incidence of preventable overdose deaths. Local teams are expected to provide crucial insights to enhance community-level responses and preventive measures.

Summary

House Bill 2194 establishes drug overdose fatality review teams in Arizona, aimed at addressing the growing public health crisis of drug overdoses. The bill amends Title 36, Chapter 1 of the Arizona Revised Statutes by introducing Article 6, which focuses on the formation and responsibilities of these review teams. The teams will be composed of members from various state agencies, judicial representatives, and health professionals, all tasked with analyzing drug overdose incidents to better understand trends and causes. This legislative effort reflects a proactive approach to tackling the complex issues surrounding drug-related fatalities in Arizona.

Sentiment

The sentiment around HB 2194 appears to be supportive among public health advocates and organizations concerned with the rising drug overdose rates. Proponents believe that a systematic approach, which includes confidentiality and the cooperation of various sectors, could lead to more effective interventions. However, there may be mixed feelings regarding the confidentiality provisions, as some stakeholders might be concerned about the transparency and accessibility of information, especially in legal contexts.

Contention

Notable points of contention include the balance between confidentiality and the need for transparent accountability in overdose investigations. The bill stipulates strict confidentiality for all information obtained during the reviews, which may raise concerns about the availability of data for public scrutiny or use in civil or criminal cases. Additionally, the implementation timeline and the operational efficacy of local review teams remain to be fully scrutinized, raising questions about the effectiveness of the proposed system in real-world applications.

Companion Bills

No companion bills found.

Similar Bills

CA AB2091

Disclosure of information: reproductive health and foreign penal civil actions.

ME LD764

An Act to Improve the Efficiency of Certain Department of Health and Human Services Licensing Investigations

AZ HB2441

Psychologist board; complaint-related documents

ME LD2215

An Act to Implement the Recommendations of the Right to Know Advisory Committee Regarding Public Records Exceptions

MT HB796

Providing for department of labor and industry and licensing boards to request health care information by administrative process

VA HB1732

Health records; disclosure of laboratory test results.

VA HB2399

Minors; parental access to health records.

NJ S3637

Establishes Office of Inspector General for Prosecutorial Review in but not of DLPS.